Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases. | Cancers (Basel) | 2022 | 35205690 | PubTator, text mining | PubMed |
| Glycans as Targets for Drug Delivery in Cancer. | Cancers (Basel) | 2022 | 35205658 | PubTator, text mining | PubMed |
| Twenty-Year Survival of Patients Operated on for Non-Small-Cell Lung Cancer: The Impact of Tumor Stage and Patient-Related Parameters. | Cancers (Basel) | 2022 | 35205621 | PubTator, text mining | PubMed |
| Multi-Level Analysis and Identification of Tumor Mutational Burden Genes across Cancer Types. | Genes (Basel) | 2022 | 35205408 | PubTator, text mining | PubMed |
| Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer. | Sci Adv | 2022 | 35196078 | PubTator, text mining | PubMed |
| Clinical, pathologic, and molecular analyses of superficial low-grade fibromyxoid sarcoma in two young patients: A rare and deceptive mimic of benignancy. | J Cutan Pathol | 2022 | 35191077 | PubTator, text mining | PubMed |
| A framework for fibrolamellar carcinoma research and clinical trials. | Nat Rev Gastroenterol Hepatol | 2022 | 35190728 | PubTator, text mining | PubMed |
| A Proximal-to-Distal Survey of Healthy Adult Human Small Intestine and Colon Epithelium by Single-Cell Transcriptomics. | Cell Mol Gastroenterol Hepatol | 2022 | 35176508 | PubTator, text mining | PubMed |
| MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia. | Leuk Lymphoma | 2022 | 35171727 | PubTator, text mining | PubMed |
| The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics-Definition, Current Advances, and Future Directions. | Cancers (Basel) | 2022 | 35159060 | PubTator, text mining | PubMed |
| Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2022 | 35158814 | PubTator, text mining | PubMed |
| Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors. | Cancers (Basel) | 2022 | 35158743 | PubTator, text mining | PubMed |
| Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn's Disease Patients. | Cell Mol Gastroenterol Hepatol | 2022 | 35158099 | PubTator, text mining | PubMed |
| HKG: an open genetic variant database of 205 Hong Kong cantonese exomes. | NAR Genom Bioinform | 2022 | 35156024 | PubTator, text mining | PubMed |
| Crosstalk Between the Gut Microbiota and Epithelial Cells Under Physiological and Infectious Conditions. | Front Cell Infect Microbiol | 2022 | 35155283 | PubTator, text mining | PubMed |
| Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies. | Theranostics | 2022 | 35154473 | PubTator, text mining | PubMed |
| Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer. | Theranostics | 2022 | 35154471 | PubTator, text mining | PubMed |
| High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope? | J Transl Med | 2022 | 35109850 | PubTator, text mining | PubMed |
| EXPRESSION OF E-CADHERIN AND CLAUDIN-3 IN THE COLONIC EPITHELIUM AFTER THE INFLIXIMAB THERAPY: EXPERIMENTAL MODEL OF DISUSE COLITIS. | Arq Bras Cir Dig | 2022 | 35107501 | PubTator, text mining | PubMed |
| Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment. | Pharmacol Res Perspect | 2022 | 35106955 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=58